International Stem Cell (ISCO) Short Interest Ratio & Short Volume

Short interest is the volume of International Stem Cell shares that have been sold short but have not yet been closed out or covered. As of July 15th, traders have sold 100 shares of ISCO short. Learn More on International Stem Cell's current short interest.

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to International Stem Cell: Ensysce Biosciences, Inc. (6.73%), Xenetic Biosciences, Inc. (2.62%), Palisade Bio, Inc. (17.10%), Briacell Therap (10.57%), Sonoma Pharmaceuticals, Inc. (1.78%), Adial Pharmaceuticals, Inc. (2.29%), InMed Pharmaceuticals Inc. (13.39%), Mainz Biomed NV (1.62%), Spruce Biosciences, Inc. (7.53%), Alaunos Therapeutics, Inc. (3.78%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($5.11 billion), Charter Communications, Inc. ($4.76 billion), Reddit Inc. ($2.84 billion), SoFi Technologies, Inc. ($2.79 billion), Seagate Technology Holdings PLC ($2.79 billion), Live Nation Entertainment, Inc. ($2.67 billion), Rocket Lab Corporation ($2.49 billion), AST SpaceMobile, Inc. ($2.12 billion), Moderna, Inc. ($2.09 billion), and Omnicom Group Inc. ($2.04 billion). View all of the most shorted stocks.

Short selling ISCO is an investing strategy that aims to generate trading profit from International Stem Cell as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for International Stem Cell occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ISCO, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ISCO, twice per month. The most recent reporting period available is July, 15 2025.